Cornell’s Research
Serves the Region and Beyond

Esper Biosciences, Inc. CTL


Esper Biosciences, Inc. is an early-stage biotechnology company developing a nanoscale sensor for high-speed DNA sequencing.  The company aims to reduce the cost of sequencing to broaden its range of targetable applications, especially in the area of medical diagnostics, where low-cost DNA sequencing offers the potential to replace many tests for individual biomarkers with a single test for many biomarkers. If successful, the company's sensors could revolutionize medicine, allowing doctors to make accurate diagnoses at the point of care, and consequently to offer more targeted treatments.

Cornell Connection

Esper's technology arose from work by cofounders Alejandro Cortese and Jonathan Alden in Paul McEuen's lab at Cornell University. The company is located in Cornell's Kevin M. McGovern Family Center for Venture Development in the Life Sciences, uses Cornell facilities, and collaborates with Cornell faculty and staff. The company's foundational technology is licensed from Cornell University.